NCT04871555 (CON-INSULA) is a clinical trial of MRI in Epilepsy, Temporal Lobe, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT04871555?

NCT04871555 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT04871555?

Interventions in NCT04871555: MRI.

What condition does NCT04871555 study?

NCT04871555 studies Epilepsy, Temporal Lobe, MRI Scans.

Is NCT04871555 still recruiting?

NCT04871555 is currently status unknown. Last updated 4 May 2021.

Last reviewed 2021-05-04 · How we verify

NCT04871555: CON-INSULA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Structural Cartography of the Insula in Temporal Epilepsy Patients

Status unknown Last updated 4 May 2021

What this trial tests

trial testing MRI in Epilepsy, Temporal Lobe in 115 participants. Status unknown.

Timeline

1 June 2021

Primary endpoint
30 April 2022

31 December 2022

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	115
Start date	1 June 2021
Primary completion	30 April 2022
Estimated completion	31 December 2022
Sites	1 location across France

Drugs / interventions tested

MRI — full drug profile →

Conditions studied

Epilepsy, Temporal Lobe — all drugs for Epilepsy, Temporal Lobe →
MRI Scans — all drugs for MRI Scans →

Sponsor

Central Hospital, Nancy, France

Who can join

15 and older, any sex, with Epilepsy, Temporal Lobe or MRI Scans. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate insula structural connectivity in temporal epilepsy patients. Insula being at the interface of frontal, parietal, occipital and temporal lobes, its structural organization reflects the brain function. We hypothetize that insular structural organization will be different according to the different subtypes of temporal epilepsy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting

Other recruiting trials for Epilepsy, Temporal Lobe

Currently open trials in the same condition.

NCT06483061 — Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy · Phase 2 · recruiting
NCT06422923 — A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE) · Phase 1, PHASE2 · recruiting
NCT06492720 — A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Re · NA · recruiting
NCT05947656 — Evaluation of the NaviFUS System in Drug Resistant Epilepsy · NA · recruiting
NCT05339438 — Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epil · NA · recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04871555 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 4 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04871555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing